David Owens Biography and Net Worth

Chief Medical Officer, Board of Directors, Scientific Advisory Board of Nexalin Technology

Dr. David Owens has been with Nexalin since 2017 when he was named Chief Medical Officer of the Company. Dr. Owens has been involved in numerous medical and software ventures over the past decade. Prior to joining Nexalin, he served with Empiric Systems, LLC, a software company specializing in radiology information systems and PACS viewing systems. He received a degree in chemistry and physics from Furman University and later a M.D from the Medical University of South Carolina in Charleston. He completed his residency and fellowship at Emory University Hospital in Neuroradiology and Interventional Neuroradiology.

What is David Owens' net worth?: The estimated net worth of David Owens is at least $39.67 thousand as of February 4th, 2025. Dr. Owens owns 5,159 shares of Nexalin Technology stock worth more than $39,673 as of August 31st. This net worth approximation does not reflect any other assets that Dr. Owens may own. Learn More about David Owens' net worth.
How do I contact David Owens?: The corporate mailing address for Dr. Owens and other Nexalin Technology executives is , , . Nexalin Technology can also be reached via phone at 832-260-0222 and via email at [email protected]. Learn More on David Owens' contact information.
Has David Owens been buying or selling shares of Nexalin Technology?: David Owens has not been actively trading shares of Nexalin Technology within the last three months. Most recently, on Tuesday, February 4th, David Owens bought 33 shares of Nexalin Technology stock. The stock was acquired at an average cost of $89.40 per share, with a total value of $2,950.20. Following the completion of the transaction, the insider now directly owns 5,159 shares of the company's stock, valued at $461,214.60. Learn More on David Owens' trading history.

David Owens Insider Trading History at Nexalin Technology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/4/2025	Buy	33	$89.40	$2,950.20	5,159
1/28/2025	Buy	50	$81.00	$4,050.00	5,126
1/23/2025	Buy	33	$81.00	$2,673.00	5,076
1/13/2025	Buy	66	$75.00	$4,950.00	5,043
10/28/2024	Buy	16	$65.70	$1,051.20	4,943
6/28/2024	Buy	33	$52.50	$1,732.50	4,893
6/10/2024	Buy	100	$19.20	$1,920.00	4,805

David Owens Buying and Selling Activity at Nexalin Technology

Nexalin Technology Company Overview

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Today's Range

Now: $7.23

$6.25

$7.69

50 Day Range

MA: $0.37

$0.25

$0.49

2 Week Range

Now: $7.23

$6.25

$60.00

Volume

31,318 shs

Average Volume

16,540 shs

Market Capitalization

$162.41 million

P/E Ratio

N/A

Dividend Yield